Telemetry Investments’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-18,190
| Closed | -$75K | – | 122 |
|
|
2017
Q1 | $75K | Sell |
18,190
-3,310
| -15% | -$13.6K | 0.03% | 87 |
|
|
2016
Q4 | $93K | Sell |
21,500
-2,167
| -9% | -$9.37K | 0.05% | 82 |
|
|
2016
Q3 | $233K | Sell |
23,667
-18,000
| -43% | -$177K | 0.15% | 66 |
|
|
2016
Q2 | $236K | Sell |
41,667
-4,333
| -9% | -$24.5K | 0.13% | 70 |
|
|
2016
Q1 | $351K | Sell |
46,000
-4,000
| -8% | -$30.5K | 0.1% | 63 |
|
|
2015
Q4 | $666K | Buy |
50,000
+10,083
| +25% | +$134K | 0.23% | 59 |
|
|
2015
Q3 | $656K | Sell |
39,917
-5,916
| -13% | -$97.2K | 0.28% | 70 |
|
|
2015
Q2 | $1.03M | Buy |
45,833
+4,166
| +10% | +$93.4K | 0.46% | 39 |
|
|
2015
Q1 | $408K | Buy |
41,667
+15,750
| +61% | +$154K | 0.23% | 79 |
|
|
2014
Q4 | $295K | Buy |
+25,917
| New | +$295K | 0.18% | 105 |
|